Industry Research Reports

Home > Reports > Pharma & Healthcare > Global and United States Basic Infusion Medicament Market Report & Forecast 2022-2028

Global and United States Basic Infusion Medicament Market Report & Forecast 2022-2028

Industry: Pharma & Healthcare

Published: 2022-05-26

Pages: 119 Pages

Report ld: 360190

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Market Analysis and Insights: Global and United States Basic Infusion Medicament Market
This report focuses on global and United States Basic Infusion Medicament market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Basic Infusion Medicament market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Glucose accounting for % of the Basic Infusion Medicament global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Packaging, max. 100ml was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Basic Infusion Medicament market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Basic Infusion Medicament Scope and Market Size
Basic Infusion Medicament market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Basic Infusion Medicament market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Basic Infusion Medicament market size by players, by Type and by Packaging, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
Glucose
Sodium Chloride
Compound Products

Segment by Packaging
max. 100ml
250ml
500ml
min. 1L

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli

 1 Study Coverage
    1.1 Basic Infusion Medicament Product Introduction
    1.2 Global Basic Infusion Medicament Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Basic Infusion Medicament Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Basic Infusion Medicament Sales in Volume for the Year 2017-2028
    1.3 United States Basic Infusion Medicament Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Basic Infusion Medicament Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Basic Infusion Medicament Sales in Volume for the Year 2017-2028
    1.4 Basic Infusion Medicament Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Basic Infusion Medicament in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Basic Infusion Medicament Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Basic Infusion Medicament Market Dynamics
        1.5.1 Basic Infusion Medicament Industry Trends
        1.5.2 Basic Infusion Medicament Market Drivers
        1.5.3 Basic Infusion Medicament Market Challenges
        1.5.4 Basic Infusion Medicament Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Basic Infusion Medicament Market Segment by Type
        2.1.1 Glucose
        2.1.2 Sodium Chloride
        2.1.3 Compound Products
    2.2 Global Basic Infusion Medicament Market Size by Type
        2.2.1 Global Basic Infusion Medicament Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Basic Infusion Medicament Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Basic Infusion Medicament Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Basic Infusion Medicament Market Size by Type
        2.3.1 United States Basic Infusion Medicament Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Basic Infusion Medicament Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Basic Infusion Medicament Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Packaging
    3.1 Basic Infusion Medicament Market Segment by Packaging
        3.1.1 max. 100ml
        3.1.2 250ml
        3.1.3 500ml
        3.1.4 min. 1L
    3.2 Global Basic Infusion Medicament Market Size by Packaging
        3.2.1 Global Basic Infusion Medicament Sales in Value, by Packaging (2017, 2022 & 2028)
        3.2.2 Global Basic Infusion Medicament Sales in Volume, by Packaging (2017, 2022 & 2028)
        3.3.3 Global Basic Infusion Medicament Average Selling Price (ASP) by Packaging (2017, 2022 & 2028)
    3.3 United States Basic Infusion Medicament Market Size by Packaging
        3.3.1 United States Basic Infusion Medicament Sales in Value, by Packaging (2017, 2022 & 2028)
        3.3.2 United States Basic Infusion Medicament Sales in Volume, by Packaging (2017, 2022 & 2028)
        3.3.3 United States Basic Infusion Medicament Average Selling Price (ASP) by Packaging (2017, 2022 & 2028)

 4 Global Basic Infusion Medicament Competitor Landscape by Company
    4.1 Global Basic Infusion Medicament Market Size by Company
        4.1.1 Top Global Basic Infusion Medicament Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Basic Infusion Medicament Revenue by Manufacturer (2017-2022)
        4.1.3 Global Basic Infusion Medicament Sales by Manufacturer (2017-2022)
        4.1.4 Global Basic Infusion Medicament Price by Manufacturer (2017-2022)
    4.2 Global Basic Infusion Medicament Concentration Ratio (CR)
        4.2.1 Basic Infusion Medicament Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Basic Infusion Medicament in 2021
        4.2.3 Global Basic Infusion Medicament Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Basic Infusion Medicament Manufacturing Base Distribution, Product Type
        4.3.1 Global Basic Infusion Medicament Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Basic Infusion Medicament Product Type
        4.3.3 Date of International Manufacturers Enter into Basic Infusion Medicament Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Basic Infusion Medicament Market Size by Company
        4.5.1 Top Basic Infusion Medicament Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Basic Infusion Medicament Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Basic Infusion Medicament Sales by Players (2020, 2021 & 2022)

 5 Global Basic Infusion Medicament Market Size by Region
    5.1 Global Basic Infusion Medicament Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Basic Infusion Medicament Market Size in Volume by Region (2017-2028)
        5.2.1 Global Basic Infusion Medicament Sales in Volume by Region: 2017-2022
        5.2.2 Global Basic Infusion Medicament Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Basic Infusion Medicament Market Size in Value by Region (2017-2028)
        5.3.1 Global Basic Infusion Medicament Sales in Value by Region: 2017-2022
        5.3.2 Global Basic Infusion Medicament Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Basic Infusion Medicament Market Size YoY Growth 2017-2028
        6.1.2 North America Basic Infusion Medicament Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Basic Infusion Medicament Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Basic Infusion Medicament Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Basic Infusion Medicament Market Size YoY Growth 2017-2028
        6.3.2 Europe Basic Infusion Medicament Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Basic Infusion Medicament Market Size YoY Growth 2017-2028
        6.4.2 Latin America Basic Infusion Medicament Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Basic Infusion Medicament Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Basic Infusion Medicament Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Baxter
        7.1.1 Baxter Corporation Information
        7.1.2 Baxter Description and Business Overview
        7.1.3 Baxter Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Baxter Basic Infusion Medicament Products Offered
        7.1.5 Baxter Recent Development
    7.2 B. Braun
        7.2.1 B. Braun Corporation Information
        7.2.2 B. Braun Description and Business Overview
        7.2.3 B. Braun Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 B. Braun Basic Infusion Medicament Products Offered
        7.2.5 B. Braun Recent Development
    7.3 Fresenius Kabi
        7.3.1 Fresenius Kabi Corporation Information
        7.3.2 Fresenius Kabi Description and Business Overview
        7.3.3 Fresenius Kabi Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Fresenius Kabi Basic Infusion Medicament Products Offered
        7.3.5 Fresenius Kabi Recent Development
    7.4 Kelun Pharma
        7.4.1 Kelun Pharma Corporation Information
        7.4.2 Kelun Pharma Description and Business Overview
        7.4.3 Kelun Pharma Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Kelun Pharma Basic Infusion Medicament Products Offered
        7.4.5 Kelun Pharma Recent Development
    7.5 Otsuka Pharmaceutical
        7.5.1 Otsuka Pharmaceutical Corporation Information
        7.5.2 Otsuka Pharmaceutical Description and Business Overview
        7.5.3 Otsuka Pharmaceutical Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Otsuka Pharmaceutical Basic Infusion Medicament Products Offered
        7.5.5 Otsuka Pharmaceutical Recent Development
    7.6 JW Pharmaceutical
        7.6.1 JW Pharmaceutical Corporation Information
        7.6.2 JW Pharmaceutical Description and Business Overview
        7.6.3 JW Pharmaceutical Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 JW Pharmaceutical Basic Infusion Medicament Products Offered
        7.6.5 JW Pharmaceutical Recent Development
    7.7 Pfizer
        7.7.1 Pfizer Corporation Information
        7.7.2 Pfizer Description and Business Overview
        7.7.3 Pfizer Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Pfizer Basic Infusion Medicament Products Offered
        7.7.5 Pfizer Recent Development
    7.8 Teva Pharmaceutical
        7.8.1 Teva Pharmaceutical Corporation Information
        7.8.2 Teva Pharmaceutical Description and Business Overview
        7.8.3 Teva Pharmaceutical Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Teva Pharmaceutical Basic Infusion Medicament Products Offered
        7.8.5 Teva Pharmaceutical Recent Development
    7.9 Haisco Pharmaceutical Group
        7.9.1 Haisco Pharmaceutical Group Corporation Information
        7.9.2 Haisco Pharmaceutical Group Description and Business Overview
        7.9.3 Haisco Pharmaceutical Group Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Haisco Pharmaceutical Group Basic Infusion Medicament Products Offered
        7.9.5 Haisco Pharmaceutical Group Recent Development
    7.10 King York
        7.10.1 King York Corporation Information
        7.10.2 King York Description and Business Overview
        7.10.3 King York Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 King York Basic Infusion Medicament Products Offered
        7.10.5 King York Recent Development
    7.11 Cisen
        7.11.1 Cisen Corporation Information
        7.11.2 Cisen Description and Business Overview
        7.11.3 Cisen Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Cisen Basic Infusion Medicament Products Offered
        7.11.5 Cisen Recent Development
    7.12 Lummy
        7.12.1 Lummy Corporation Information
        7.12.2 Lummy Description and Business Overview
        7.12.3 Lummy Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Lummy Products Offered
        7.12.5 Lummy Recent Development
    7.13 Grand Life Sciences
        7.13.1 Grand Life Sciences Corporation Information
        7.13.2 Grand Life Sciences Description and Business Overview
        7.13.3 Grand Life Sciences Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Grand Life Sciences Products Offered
        7.13.5 Grand Life Sciences Recent Development
    7.14 Medisan
        7.14.1 Medisan Corporation Information
        7.14.2 Medisan Description and Business Overview
        7.14.3 Medisan Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Medisan Products Offered
        7.14.5 Medisan Recent Development
    7.15 BBCA Pharmaceutical
        7.15.1 BBCA Pharmaceutical Corporation Information
        7.15.2 BBCA Pharmaceutical Description and Business Overview
        7.15.3 BBCA Pharmaceutical Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 BBCA Pharmaceutical Products Offered
        7.15.5 BBCA Pharmaceutical Recent Development
    7.16 Biokin Pharmaceutical
        7.16.1 Biokin Pharmaceutical Corporation Information
        7.16.2 Biokin Pharmaceutical Description and Business Overview
        7.16.3 Biokin Pharmaceutical Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 Biokin Pharmaceutical Products Offered
        7.16.5 Biokin Pharmaceutical Recent Development
    7.17 Xi'an Libang Pharmaceutical
        7.17.1 Xi'an Libang Pharmaceutical Corporation Information
        7.17.2 Xi'an Libang Pharmaceutical Description and Business Overview
        7.17.3 Xi'an Libang Pharmaceutical Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 Xi'an Libang Pharmaceutical Products Offered
        7.17.5 Xi'an Libang Pharmaceutical Recent Development
    7.18 Lionco Pharmaceutical
        7.18.1 Lionco Pharmaceutical Corporation Information
        7.18.2 Lionco Pharmaceutical Description and Business Overview
        7.18.3 Lionco Pharmaceutical Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.18.4 Lionco Pharmaceutical Products Offered
        7.18.5 Lionco Pharmaceutical Recent Development
    7.19 China Meheco Kangli
        7.19.1 China Meheco Kangli Corporation Information
        7.19.2 China Meheco Kangli Description and Business Overview
        7.19.3 China Meheco Kangli Basic Infusion Medicament Sales, Revenue and Gross Margin (2017-2022)
        7.19.4 China Meheco Kangli Products Offered
        7.19.5 China Meheco Kangli Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Basic Infusion Medicament Industry Chain Analysis
    8.2 Basic Infusion Medicament Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Basic Infusion Medicament Distributors
    8.3 Basic Infusion Medicament Production Mode & Process
    8.4 Basic Infusion Medicament Sales and Marketing
        8.4.1 Basic Infusion Medicament Sales Channels
        8.4.2 Basic Infusion Medicament Distributors
    8.5 Basic Infusion Medicament Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Basic Infusion Medicament CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Basic Infusion Medicament Market Trends
    Table 3. Basic Infusion Medicament Market Drivers
    Table 4. Basic Infusion Medicament Market Challenges
    Table 5. Basic Infusion Medicament Market Restraints
    Table 6. Global Basic Infusion Medicament Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Basic Infusion Medicament Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Basic Infusion Medicament Sales by Packaging: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Basic Infusion Medicament Sales by Packaging: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Basic Infusion Medicament Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Basic Infusion Medicament Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Basic Infusion Medicament Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Basic Infusion Medicament Sales by Manufacturer, (Tons), 2017-2022
    Table 14. Global Basic Infusion Medicament Sales Share by Manufacturer, 2017-2022
    Table 15. Global Basic Infusion Medicament Price by Manufacturer (2017-2022) & (US$/Ton)
    Table 16. Global Basic Infusion Medicament Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Basic Infusion Medicament by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basic Infusion Medicament as of 2021)
    Table 18. Top Players of Basic Infusion Medicament in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Basic Infusion Medicament Product Type
    Table 20. Date of International Manufacturers Enter into Basic Infusion Medicament Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Basic Infusion Medicament Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Basic Infusion Medicament Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Basic Infusion Medicament Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Basic Infusion Medicament Sales by Players, (Tons), 2020, 2021 & 2022
    Table 26. United States Basic Infusion Medicament Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Basic Infusion Medicament Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Basic Infusion Medicament Sales in Volume by Region (2017-2022) & (Tons)
    Table 29. Global Basic Infusion Medicament Sales in Volume Forecast by Region (2023-2028) & (Tons)
    Table 30. Global Basic Infusion Medicament Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Basic Infusion Medicament Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Basic Infusion Medicament Sales in Volume by Country (2017-2028) & (Tons)
    Table 33. North America Basic Infusion Medicament Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Basic Infusion Medicament Sales in Volume by Region (2017-2028) & (Tons)
    Table 35. Asia Pacific Basic Infusion Medicament Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Basic Infusion Medicament Sales in Volume by Country (2017-2028) & (Tons)
    Table 37. Europe Basic Infusion Medicament Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Basic Infusion Medicament Sales in Volume by Country (2017-2028) & (Tons)
    Table 39. Latin Americaa Basic Infusion Medicament Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Basic Infusion Medicament Sales in Volume by Country (2017-2028) & (Tons)
    Table 41. Middle East and Africa Basic Infusion Medicament Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Baxter Corporation Information
    Table 43. Baxter Description and Business Overview
    Table 44. Baxter Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 45. Baxter Basic Infusion Medicament Product
    Table 46. Baxter Recent Development
    Table 47. B. Braun Corporation Information
    Table 48. B. Braun Description and Business Overview
    Table 49. B. Braun Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 50. B. Braun Product
    Table 51. B. Braun Recent Development
    Table 52. Fresenius Kabi Corporation Information
    Table 53. Fresenius Kabi Description and Business Overview
    Table 54. Fresenius Kabi Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 55. Fresenius Kabi Product
    Table 56. Fresenius Kabi Recent Development
    Table 57. Kelun Pharma Corporation Information
    Table 58. Kelun Pharma Description and Business Overview
    Table 59. Kelun Pharma Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 60. Kelun Pharma Product
    Table 61. Kelun Pharma Recent Development
    Table 62. Otsuka Pharmaceutical Corporation Information
    Table 63. Otsuka Pharmaceutical Description and Business Overview
    Table 64. Otsuka Pharmaceutical Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 65. Otsuka Pharmaceutical Product
    Table 66. Otsuka Pharmaceutical Recent Development
    Table 67. JW Pharmaceutical Corporation Information
    Table 68. JW Pharmaceutical Description and Business Overview
    Table 69. JW Pharmaceutical Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 70. JW Pharmaceutical Product
    Table 71. JW Pharmaceutical Recent Development
    Table 72. Pfizer Corporation Information
    Table 73. Pfizer Description and Business Overview
    Table 74. Pfizer Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 75. Pfizer Product
    Table 76. Pfizer Recent Development
    Table 77. Teva Pharmaceutical Corporation Information
    Table 78. Teva Pharmaceutical Description and Business Overview
    Table 79. Teva Pharmaceutical Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 80. Teva Pharmaceutical Product
    Table 81. Teva Pharmaceutical Recent Development
    Table 82. Haisco Pharmaceutical Group Corporation Information
    Table 83. Haisco Pharmaceutical Group Description and Business Overview
    Table 84. Haisco Pharmaceutical Group Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 85. Haisco Pharmaceutical Group Product
    Table 86. Haisco Pharmaceutical Group Recent Development
    Table 87. King York Corporation Information
    Table 88. King York Description and Business Overview
    Table 89. King York Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 90. King York Product
    Table 91. King York Recent Development
    Table 92. Cisen Corporation Information
    Table 93. Cisen Description and Business Overview
    Table 94. Cisen Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 95. Cisen Product
    Table 96. Cisen Recent Development
    Table 97. Lummy Corporation Information
    Table 98. Lummy Description and Business Overview
    Table 99. Lummy Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 100. Lummy Product
    Table 101. Lummy Recent Development
    Table 102. Grand Life Sciences Corporation Information
    Table 103. Grand Life Sciences Description and Business Overview
    Table 104. Grand Life Sciences Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 105. Grand Life Sciences Product
    Table 106. Grand Life Sciences Recent Development
    Table 107. Medisan Corporation Information
    Table 108. Medisan Description and Business Overview
    Table 109. Medisan Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 110. Medisan Product
    Table 111. Medisan Recent Development
    Table 112. BBCA Pharmaceutical Corporation Information
    Table 113. BBCA Pharmaceutical Description and Business Overview
    Table 114. BBCA Pharmaceutical Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 115. BBCA Pharmaceutical Product
    Table 116. BBCA Pharmaceutical Recent Development
    Table 117. Biokin Pharmaceutical Corporation Information
    Table 118. Biokin Pharmaceutical Description and Business Overview
    Table 119. Biokin Pharmaceutical Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 120. Biokin Pharmaceutical Product
    Table 121. Biokin Pharmaceutical Recent Development
    Table 122. Xi'an Libang Pharmaceutical Corporation Information
    Table 123. Xi'an Libang Pharmaceutical Description and Business Overview
    Table 124. Xi'an Libang Pharmaceutical Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 125. Xi'an Libang Pharmaceutical Product
    Table 126. Xi'an Libang Pharmaceutical Recent Development
    Table 127. Lionco Pharmaceutical Corporation Information
    Table 128. Lionco Pharmaceutical Description and Business Overview
    Table 129. Lionco Pharmaceutical Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 130. Lionco Pharmaceutical Product
    Table 131. Lionco Pharmaceutical Recent Development
    Table 132. China Meheco Kangli Corporation Information
    Table 133. China Meheco Kangli Description and Business Overview
    Table 134. China Meheco Kangli Basic Infusion Medicament Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 135. China Meheco Kangli Product
    Table 136. China Meheco Kangli Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Basic Infusion Medicament Customers List
    Table 140. Basic Infusion Medicament Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Basic Infusion Medicament Product Picture
    Figure 2. Global Basic Infusion Medicament Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Basic Infusion Medicament Market Size 2017-2028 (US$ Million)
    Figure 4. Global Basic Infusion Medicament Sales 2017-2028 (Tons)
    Figure 5. United States Basic Infusion Medicament Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Basic Infusion Medicament Market Size 2017-2028 (US$ Million)
    Figure 7. United States Basic Infusion Medicament Sales 2017-2028 (Tons)
    Figure 8. United States Basic Infusion Medicament Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Basic Infusion Medicament Market Share in Global, in Volume (Tons) 2017-2028
    Figure 10. Basic Infusion Medicament Report Years Considered
    Figure 11. Product Picture of Glucose
    Figure 12. Product Picture of Sodium Chloride
    Figure 13. Product Picture of Compound Products
    Figure 14. Global Basic Infusion Medicament Market Share by Type in 2022 & 2028
    Figure 15. Global Basic Infusion Medicament Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Basic Infusion Medicament Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Basic Infusion Medicament Sales by Type (2017-2028) & (Tons)
    Figure 18. Global Basic Infusion Medicament Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Basic Infusion Medicament Price by Type (2017-2028) & (US$/Ton)
    Figure 20. United States Basic Infusion Medicament Market Share by Type in 2022 & 2028
    Figure 21. United States Basic Infusion Medicament Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Basic Infusion Medicament Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Basic Infusion Medicament Sales by Type (2017-2028) & (Tons)
    Figure 24. United States Basic Infusion Medicament Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Basic Infusion Medicament Price by Type (2017-2028) & (US$/Ton)
    Figure 26. Product Picture of max. 100ml
    Figure 27. Product Picture of 250ml
    Figure 28. Product Picture of 500ml
    Figure 29. Product Picture of min. 1L
    Figure 30. Global Basic Infusion Medicament Market Share by Packaging in 2022 & 2028
    Figure 31. Global Basic Infusion Medicament Sales in Value by Packaging (2017-2028) & (US$ Million)
    Figure 32. Global Basic Infusion Medicament Sales Market Share in Value by Packaging (2017-2028)
    Figure 33. Global Basic Infusion Medicament Sales by Packaging (2017-2028) & (Tons)
    Figure 34. Global Basic Infusion Medicament Sales Market Share in Volume by Packaging (2017-2028)
    Figure 35. Global Basic Infusion Medicament Price by Packaging (2017-2028) & (US$/Ton)
    Figure 36. United States Basic Infusion Medicament Market Share by Packaging in 2022 & 2028
    Figure 37. United States Basic Infusion Medicament Sales in Value by Packaging (2017-2028) & (US$ Million)
    Figure 38. United States Basic Infusion Medicament Sales Market Share in Value by Packaging (2017-2028)
    Figure 39. United States Basic Infusion Medicament Sales by Packaging (2017-2028) & (Tons)
    Figure 40. United States Basic Infusion Medicament Sales Market Share in Volume by Packaging (2017-2028)
    Figure 41. United States Basic Infusion Medicament Price by Packaging (2017-2028) & (US$/Ton)
    Figure 42. North America Basic Infusion Medicament Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 43. North America Basic Infusion Medicament Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. United States Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Basic Infusion Medicament Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 47. Europe Basic Infusion Medicament Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Basic Infusion Medicament Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 54. Asia-Pacific Basic Infusion Medicament Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. China Taiwan Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Basic Infusion Medicament Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 65. Latin America Basic Infusion Medicament Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Colombia Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Basic Infusion Medicament Sales in Volume Growth Rate 2017-2028 (Tons)
    Figure 71. Middle East & Africa Basic Infusion Medicament Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. UAE Basic Infusion Medicament Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Basic Infusion Medicament Value Chain
    Figure 76. Basic Infusion Medicament Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed

Market Analysis and Insights: Global and United States Basic Infusion Medicament Market
This report focuses on global and United States Basic Infusion Medicament market, also covers the segmentation data of other regions in regional level and county level.

In United States the Basic Infusion Medicament market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Segment by Type
Glucose
Sodium Chloride
Compound Products

Segment by Packaging
max. 100ml
250ml
500ml
min. 1L

Industry: Pharma & Healthcare

Published: 2022-05-26

Pages: 119 Pages

Report ld: 360190

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4350.00

Multi Users License

USD 6525.00

Corporate Users License

USD 8700.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?